Cargando...
Characterization of Atomoxetine Biotransformation and Implications for Development of PBPK Models for Dose Individualization in Children
Atomoxetine (ATX) is a second-line nonstimulant medication used to control symptoms of attention deficit hyperactivity disorder (ADHD). Inconsistent therapeutic efficacy has been reported with ATX, which may be related to variable CYP2D6-mediated drug clearance. We characterized ATX metabolism in a...
Gardado en:
| Publicado en: | Drug Metab Dispos |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
The American Society for Pharmacology and Experimental Therapeutics
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4931890/ https://ncbi.nlm.nih.gov/pubmed/27052878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.116.069518 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|